INTERNATIONAL PATENT: SHENZHEN RESEARCH INSTITUTE BEIJING UNIVERSITY OF CHINESE MEDICINE, 深圳北京中医药大学研究院 FILES APPLICATION FOR "SARS-COV-2 CAMELID-DERIVED NANOBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND COMPOSITION THEREOF AND USE THEREOF"

GENEVA, Oct. 26 -- SHENZHEN RESEARCH INSTITUTE BEIJING UNIVERSITY OF CHINESE MEDICINE (A08~A12, Guofu Cultural Creative Industry Factory, Pingshan DistrictShenzhen, Guangdong 518118), 深圳北京中医药大学研究院 (中国广东省深圳市坪山区国富文化创意产业厂区厂房A08~A12) filed a patent application (PCT/CN2024/102760) for "SARS-COV-2 CAMELID-DERIVED NANOBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND COMPOSITION THEREOF AND USE THEREOF" on Jun 29, 2024. With publication no. WO/2025/218020, the details related to the patent application was publi...